CCLA Investment Management Acquires 124,390 Shares of Zoetis Inc. $ZTS

CCLA Investment Management increased its holdings in Zoetis Inc. (NYSE:ZTS) by 14.9% during the 2nd quarter, Holdings Channel reports. The firm owned 959,604 shares of the company’s stock after buying an additional 124,390 shares during the period. Zoetis makes up approximately 0.1% of CCLA Investment Management’s investment portfolio, making the stock its 17th biggest position. CCLA Investment Management’s holdings in Zoetis were worth $149,583,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of ZTS. Brighton Jones LLC grew its stake in shares of Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after purchasing an additional 2,978 shares during the last quarter. Trust Co. of Vermont grew its stake in shares of Zoetis by 9.7% in the first quarter. Trust Co. of Vermont now owns 1,193 shares of the company’s stock worth $196,000 after purchasing an additional 105 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Zoetis by 4.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 68,508 shares of the company’s stock worth $11,183,000 after purchasing an additional 2,748 shares during the last quarter. BSW Wealth Partners bought a new stake in shares of Zoetis in the first quarter worth about $254,000. Finally, K.J. Harrison & Partners Inc grew its stake in shares of Zoetis by 5.0% in the first quarter. K.J. Harrison & Partners Inc now owns 4,685 shares of the company’s stock worth $771,000 after purchasing an additional 225 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. UBS Group cut their target price on Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a research note on Monday, October 20th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $180.00 to $155.00 in a report on Thursday, July 17th. Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a report on Friday. Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Finally, Piper Sandler raised their price objective on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $195.00.

Zoetis Price Performance

ZTS stock opened at $146.14 on Monday. The firm has a 50 day moving average price of $148.18 and a 200-day moving average price of $153.57. Zoetis Inc. has a 52-week low of $139.34 and a 52-week high of $184.40. The firm has a market capitalization of $64.77 billion, a price-to-earnings ratio of 25.15, a PEG ratio of 2.35 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the business earned $1.56 earnings per share. The business’s revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.